Cat.#: ACPP-1232
| Despition | GPCR GPR15 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1152 | PAX5 Blocking Peptide (AC1152) | 250 µg | inquiry |
| ACPP-1481 | Human RDH12 Protein (AC1481) | 2 µg | inquiry |
| ACPP-1081 | Human NRN1 Protein (AC1081) | 5 µg | inquiry |
| ACPP-1387 | Human ARC Protein (AC1387) | 1 µg | inquiry |
| ACPP-1819 | Human TRH Protein (AC1819) | 100 mg | inquiry |
| ACPP-1241 | Dopamine Receptor D4 Blocking Peptide (AC1241) | 250 µg | inquiry |
| ACPP-1027 | Recombinant Human Ephrin A3 Protein (Fc Tag) (AC1027) | 50 µg | inquiry |
| ACPP-1557 | Human TARDBP Protein (AC1557) | 2 µg | inquiry |
| ACPP-1646 | Human DNAJB6 Protein (AC1646) | 1 µg | inquiry |
| ACPP-1021 | Recombinant Human PGP9.5 Protein (Fc Tag) (AC1021) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.